General Blood Safety

Would you like to learn more about current standards and processes in blood safety? The INTERCEPT™ Blood System enables blood centres worldwide to produce safe blood components. You can find out more here about how it works, and its affordability.

  • icon-bloodsafety2_1.png

    Blood safety

    Blood and blood components are key elements in treating patients. But blood can contain potentially harmful elements such as bacteria, viruses and parasites, which can be transmitted to the patient.
    Read more about Blood Safety
  • icon-economics2_1.png

    Cost-effectiveness

    The adoption of pathogen inactivation for all three components offers the potential for numerous cost-saving initiatives.
    Read more about Cost-effectiveness
  • icon-intercept2_1.png

    INTERCEPT

    The INTERCEPT™ Blood System is intended for the preparation and storage of donated platelets and plasma in order to reduce the risk of transfusion-transmitted infections.
    Read more about INTERCEPT

Proven in Routine Use

Regulatory authorities concluded that INTERCEPT Platelets and Plasma are not clinically different from untreated products and may be prescribed and transfused in accordance with standard infusion methods.

The INTERCEPT Blood System is currently used to inactivate pathogens in platelets and plasma across Europe, CIS, the Middle East and USA.

The INTERCEPT™ Blood System is designed to reduce the risk of transfusion-transmitted diseases